Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS

Table of Contents

October 01, 2007; Volume 34,Issue 10
  • You have access
    Can we combine patient's and doctor's perspective when assessing rheumatoid arthritis disease activity?
    Maxime Dougados
    The Journal of Rheumatology October 1 2007, 34 (10) 1949-1952;
  • You have access
    Does medical insurance matter in the progression to endstage renal disease among patients with lupus nephritis?
    Luis A González and Graciela S Alarcón
    The Journal of Rheumatology October 1 2007, 34 (10) 1953-1954;
  • You have access
    Learning how and when to employ uricase as bridge therapy in refractory gout.
    Robert Terkeltaub
    The Journal of Rheumatology October 1 2007, 34 (10) 1955-1958;
  • You have access
    Longterm culture of telomerase-transduced rheumatoid arthritis fibroblast-like synoviocytes display a distinct gene expression pattern.
    Yubo Sun, Gary Firestein, David Boyle, Helen Gruber and Herman Cheung
    The Journal of Rheumatology October 1 2007, 34 (10) 1959-1970;
  • You have access
    Bone mineral density in older adult patients with rheumatoid arthritis: an analysis of NHANES III.
    Mitsuyo Kinjo, Soko Setoguchi and Daniel H Solomon
    The Journal of Rheumatology October 1 2007, 34 (10) 1971-1975;
  • You have access
    Increased nuclear factor-kappaB activation in peripheral blood monocytes of patients with rheumatoid arthritis is mediated primarily by tumor necrosis factor-alpha.
    Isabelle Dichamp, Alain Bourgeois, Carine Dirand, Georges Herbein and Daniel Wendling
    The Journal of Rheumatology October 1 2007, 34 (10) 1976-1983;
  • You have access
    Association of PTPN22 with rheumatoid arthritis among South Asians in the UK.
    Sarabjit Mastana, Ashley Gilmour, Anant Ghelani, Hannah Smith and Ash Samanta
    The Journal of Rheumatology October 1 2007, 34 (10) 1984-1986;
  • You have access
    Disease activity score 28 as an instrument to measure disease activity in patients with early rheumatoid arthritis.
    Heidi Mäkinen, Hannu Kautiainen, Pekka Hannonen, Timo Möttönen, Markku Korpela, Marjatta Leirisalo-Repo, Reijo Luukkainen, Kari Puolakka, Anna Karjalainen and Tuulikki Sokka
    The Journal of Rheumatology October 1 2007, 34 (10) 1987-1991;
  • You have access
    Decrease of disease activity under ineffective therapy in DMARD-naive patients with early rheumatoid arthritis: role of antibody profiles and carriage of the HLA shared epitope in predicting decrease of disease activity.
    Bert Vander Cruyssen, André M M Miltenburg, Filip Van den Bosch, Jos G A Houbiers, Ruth Wittoek, Annemieke M H Boots and Filip De Keyser
    The Journal of Rheumatology October 1 2007, 34 (10) 1992-1996;
  • You have access
    Infliximab but not methotrexate induces extra-high levels of VLDL-triglyceride in patients with rheumatoid arthritis.
    Osamu Saiki, Rikio Takao, Yuko Naruse, Makihiko Kuhara, Saeko Imai and Hiroshi Uda
    The Journal of Rheumatology October 1 2007, 34 (10) 1997-2004;
  • You have access
    Myocardial dysfunction in rheumatoid arthritis: a controlled tissue-Doppler echocardiography study.
    Christophe Meune, Karim Wahbi, Noémie Assous, Simon Weber, André Kahan and Yannick Allanore
    The Journal of Rheumatology October 1 2007, 34 (10) 2005-2009;
  • You have access
    Diagnostic reliability of cerebral spinal fluid tests for acute confusional state (delirium) in patients with systemic lupus erythematosus: interleukin 6 (IL-6), IL-8, interferon-alpha, IgG index, and Q-albumin.
    Yasuhiro Katsumata, Masayoshi Harigai, Yasushi Kawaguchi, Chikako Fukasawa, Makoto Soejima, Kae Takagi, Michi Tanaka, Hisae Ichida, Akiko Tochimoto, Tokiko Kanno, Katsuji Nishimura, Naoyuki Kamatani and Masako Hara
    The Journal of Rheumatology October 1 2007, 34 (10) 2010-2017;
  • You have access
    Self-reported fractures and associated factors in women with systemic lupus erythematosus.
    Chin Lee, Orit Almagor, Dorothy D Dunlop, Susan Manzi, Stewart Spies and Rosalind Ramsey-Goldman
    The Journal of Rheumatology October 1 2007, 34 (10) 2018-2023;
  • You have access
    Medical insurance, socioeconomic status, and age of onset of endstage renal disease in patients with lupus nephritis.
    Michael M Ward
    The Journal of Rheumatology October 1 2007, 34 (10) 2024-2027;
  • You have access
    Association of the G-463A myeloperoxidase gene polymorphism with renal disease in African Americans with systemic lupus erythematosus.
    Henda Bouali, Paul Nietert, Tamara M Nowling, Janardan Pandey, Mary Anne Dooley, Glinda Cooper, John Harley, Diane L Kamen, Jim Oates and Gary Gilkeson
    The Journal of Rheumatology October 1 2007, 34 (10) 2028-2034;
  • You have access
    Thioredoxin may exert a protective effect against tissue damage caused by oxidative stress in salivary glands of patients with Sjögren's syndrome.
    Chiyo Kurimoto, Seiji Kawano, Goh Tsuji, Saori Hatachi, Takumi Jikimoto, Daisuke Sugiyama, Shimpei Kasagi, Takahide Komori, Hajime Nakamura, Junji Yodoi and Shunichi Kumagai
    The Journal of Rheumatology October 1 2007, 34 (10) 2035-2043;
  • You have access
    Serological implications of germinal center-like structures in primary Sjögren's syndrome.
    Malin V Jonsson, Kathrine Skarstein, Roland Jonsson and Johan G Brun
    The Journal of Rheumatology October 1 2007, 34 (10) 2044-2049;
  • You have access
    Characteristics of patients with early systemic sclerosis and severe gastrointestinal tract involvement.
    Emi Nishimagi, Akiko Tochimoto, Yasushi Kawaguchi, Takashi Satoh, Masataka Kuwana, Kae Takagi, Hisae Ichida, Tokiko Kanno, Makoto Soejima, Sayumi Baba, Naoyuki Kamatani and Masako Hara
    The Journal of Rheumatology October 1 2007, 34 (10) 2050-2055;
  • You have access
    Elevated serum APRIL levels in patients with systemic sclerosis: distinct profiles of systemic sclerosis categorized by APRIL and BAFF.
    Takashi Matsushita, Manabu Fujimoto, Minoru Hasegawa, Chihiro Tanaka, Sayako Kumada, Fumihide Ogawa, Kazuhiko Takehara and Shinichi Sato
    The Journal of Rheumatology October 1 2007, 34 (10) 2056-2062;
  • You have access
    Specific proteins identified in whole saliva from patients with diffuse systemic sclerosis.
    Laura Giusti, Laura Bazzichi, Chiara Baldini, Federica Ciregia, Giovanni Mascia, Gino Giannaccini, Mario Del Rosso, Stefano Bombardieri and Antonio Lucacchini
    The Journal of Rheumatology October 1 2007, 34 (10) 2063-2069;
  • You have access
    The rate of pyrin mutations in critically ill patients with systemic inflammatory response syndrome and sepsis: a pilot study.
    Bayram Koc, Cagatay Oktenli, Fatih Bulucu, Nuri Karadurmus, S Yavuz Sanisoglu and Davut Gul
    The Journal of Rheumatology October 1 2007, 34 (10) 2070-2075;
  • You have access
    Mannose binding lectin levels in spondyloarthropathies.
    Sibel Zehra Aydin, Pamir Atagunduz, Nevsun Inanc, Muge Bicakcigil, Demet Tasan, Musa Temel and Haner Direskeneli
    The Journal of Rheumatology October 1 2007, 34 (10) 2075-2077;
  • You have access
    C-reactive protein predicts tumor necrosis factor-alpha blocker retention rate in axial ankylosing spondylitis.
    Mathieu Luc, Laure Gossec, Adeline Ruyssen-Witrand, Carine Salliot, Muriel Duclos, Sandra Guignard and Maxime Dougados
    The Journal of Rheumatology October 1 2007, 34 (10) 2078-2081;
  • You have access
    Psoriatic arthritis in Reykjavik, Iceland: prevalence, demographics, and disease course.
    Thorvardur Jon Love, Bjorn Gudbjornsson, Johann Eli Gudjonsson and Helgi Valdimarsson
    The Journal of Rheumatology October 1 2007, 34 (10) 2082-2088;
  • You have access
    S100 proteins calprotectin and S100A12 are related to radiographic changes rather than disease activity in psoriatic arthritis with low disease activity.
    Tor Magne Madland, Annette Larsen and Johan G Brun
    The Journal of Rheumatology October 1 2007, 34 (10) 2089-2092;
  • You have access
    Rasburicase for tophaceous gout not treatable with allopurinol: an exploratory study.
    Pascal Richette, Claire Brière, Virginie Hoenen-Clavert, Damien Loeuille and Thomas Bardin
    The Journal of Rheumatology October 1 2007, 34 (10) 2093-2098;
  • You have access
    Knee osteoarthritis clinical practice guidelines -- how are we doing?
    Melanie N DeHaan, Jaime Guzman, Mark Theodore Bayley and Mary J Bell
    The Journal of Rheumatology October 1 2007, 34 (10) 2099-2105;
  • You have access
    Assessment of disease activity in juvenile idiopathic arthritis. The number and the size of joints matter.
    Lillemor Berntson, Lisa Wernroth, Anders Fasth, Kristiina Aalto, Troels Herlin, Susan Nielsen, Ellen Nordal, Marite Rygg and Marek Zak
    The Journal of Rheumatology October 1 2007, 34 (10) 2106-2111;
  • You have access
    Predictors of lipid abnormalities in children with new-onset systemic lupus erythematosus.
    Pascal N Tyrrell, Joseph Beyene, Susanne M Benseler, Talin Sarkissian and Earl D Silverman
    The Journal of Rheumatology October 1 2007, 34 (10) 2112-2119;
  • You have access
    Progressive multifocal leukoencephalopathy mimicking central nervous system lupus.
    Jefferson R Roberts and David R Finger
    The Journal of Rheumatology October 1 2007, 34 (10) 2119-2120;
  • You have access
    Early stage spine infarct accurately diagnosed by 99m Tc-HMDP bone scintigraphy performed on a combined single photon emission computed tomography/computed tomography system correlation with magnetic resonance imaging and histopathological findings.
    Nicolas Aide, Thierry Franson, Brigitte Marie, Jacques Chasle, François Lesaunier and Stéphane Bardet
    The Journal of Rheumatology October 1 2007, 34 (10) 2121-2122;
Back to top
PreviousNext

In this issue

The Journal of Rheumatology
Vol. 34, Issue 10
1 Oct 2007
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Most Read
  • ​ Editor's Picks
  • E-letters
Loading
  • IgA Vasculitis Following COVID-19 Vaccination: A French Multicenter Case Series Including 12 Patients
  • Effects of Bedtime Very Low Dose Cyclobenzaprine on Symptoms and Sleep Physiology in Patients with Fibromyalgia Syndrome: A Double-blind Randomized Placebo-controlled Study
  • Ro52, Myositis, and Interstitial Lung Disease
  • Management of Enthesitis in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations
  • Management of Axial Disease in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations
More...

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2022 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire